Cargando…

Validation of the generalized anxiety disorder scales (GAD-7 and GAD-2) in primary care settings in Latvia

BACKGROUND: Anxiety disorders are the most prevalent mental disorders in the world and have an important impact on the global burden of disease. Generalized anxiety disorder (GAD) is the most prevalent anxiety disorder encountered in primary care. There are no available validated anxiety screening t...

Descripción completa

Detalles Bibliográficos
Autores principales: Vrublevska, Jelena, Renemane, Lubova, Kivite-Urtane, Anda, Rancans, Elmars
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9583259/
https://www.ncbi.nlm.nih.gov/pubmed/36276320
http://dx.doi.org/10.3389/fpsyt.2022.972628
_version_ 1784813031841071104
author Vrublevska, Jelena
Renemane, Lubova
Kivite-Urtane, Anda
Rancans, Elmars
author_facet Vrublevska, Jelena
Renemane, Lubova
Kivite-Urtane, Anda
Rancans, Elmars
author_sort Vrublevska, Jelena
collection PubMed
description BACKGROUND: Anxiety disorders are the most prevalent mental disorders in the world and have an important impact on the global burden of disease. Generalized anxiety disorder (GAD) is the most prevalent anxiety disorder encountered in primary care. There are no available validated anxiety screening tools in primary care in Latvia. We aimed to validate both a seven-item and a two-item generalized anxiety disorder scale (GAD-7 and GAD-2) in the Latvian and Russian languages, to detect generalized anxiety disorder (GAD) in primary care settings in Latvia. METHODS: During a 1-week period, all patients aged 18 years or older visiting their GP (general practitioners) with any health concern at 24 primary care settings throughout Latvia were invited to complete the GAD-7 in their native language (Latvian or Russian). Criterion validity was assessed against the Mini International Neuropsychiatric Interview (MINI). RESULTS: The study sample included 1,459 participants who completed the GAD-7 and the MINI. The GAD-7 items showed good internal reliability [Cronbach's alpha 0.87 for Latvian version and 0.85 for Russian version (for Latvia) of the GAD-7]. A cut-off score for detecting GAD of 5 or above was estimated for Latvian version of the GAD-7 (sensitivity 75.4%, specificity 68.9%, respectively) and 7 or above for Russian version of the GAD-7 (sensitivity 73.3%, specificity 84.1%, respectively). The internal reliability of the GAD-2 was lower for both languages (Cronbach's alpha 0.75 for Latvian version and 0.68 for Russian version of the GAD-2). A cut-off score of 2 or above was established for both the Latvian, and Russian versions of the GAD-2 (sensitivity 78.9 and 83.3%; specificity 63.7 and 69.1% for the Latvian and Russian versions of the GAD-2, accordingly) for detecting GAD. CONCLUSIONS: This is the first study to report criterion validity of the Latvian and Russian (for Latvia) versions of the GAD-7 and GAD-2, assessed in a nationwide study conducted at the primary care level.
format Online
Article
Text
id pubmed-9583259
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-95832592022-10-21 Validation of the generalized anxiety disorder scales (GAD-7 and GAD-2) in primary care settings in Latvia Vrublevska, Jelena Renemane, Lubova Kivite-Urtane, Anda Rancans, Elmars Front Psychiatry Psychiatry BACKGROUND: Anxiety disorders are the most prevalent mental disorders in the world and have an important impact on the global burden of disease. Generalized anxiety disorder (GAD) is the most prevalent anxiety disorder encountered in primary care. There are no available validated anxiety screening tools in primary care in Latvia. We aimed to validate both a seven-item and a two-item generalized anxiety disorder scale (GAD-7 and GAD-2) in the Latvian and Russian languages, to detect generalized anxiety disorder (GAD) in primary care settings in Latvia. METHODS: During a 1-week period, all patients aged 18 years or older visiting their GP (general practitioners) with any health concern at 24 primary care settings throughout Latvia were invited to complete the GAD-7 in their native language (Latvian or Russian). Criterion validity was assessed against the Mini International Neuropsychiatric Interview (MINI). RESULTS: The study sample included 1,459 participants who completed the GAD-7 and the MINI. The GAD-7 items showed good internal reliability [Cronbach's alpha 0.87 for Latvian version and 0.85 for Russian version (for Latvia) of the GAD-7]. A cut-off score for detecting GAD of 5 or above was estimated for Latvian version of the GAD-7 (sensitivity 75.4%, specificity 68.9%, respectively) and 7 or above for Russian version of the GAD-7 (sensitivity 73.3%, specificity 84.1%, respectively). The internal reliability of the GAD-2 was lower for both languages (Cronbach's alpha 0.75 for Latvian version and 0.68 for Russian version of the GAD-2). A cut-off score of 2 or above was established for both the Latvian, and Russian versions of the GAD-2 (sensitivity 78.9 and 83.3%; specificity 63.7 and 69.1% for the Latvian and Russian versions of the GAD-2, accordingly) for detecting GAD. CONCLUSIONS: This is the first study to report criterion validity of the Latvian and Russian (for Latvia) versions of the GAD-7 and GAD-2, assessed in a nationwide study conducted at the primary care level. Frontiers Media S.A. 2022-10-06 /pmc/articles/PMC9583259/ /pubmed/36276320 http://dx.doi.org/10.3389/fpsyt.2022.972628 Text en Copyright © 2022 Vrublevska, Renemane, Kivite-Urtane and Rancans. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Psychiatry
Vrublevska, Jelena
Renemane, Lubova
Kivite-Urtane, Anda
Rancans, Elmars
Validation of the generalized anxiety disorder scales (GAD-7 and GAD-2) in primary care settings in Latvia
title Validation of the generalized anxiety disorder scales (GAD-7 and GAD-2) in primary care settings in Latvia
title_full Validation of the generalized anxiety disorder scales (GAD-7 and GAD-2) in primary care settings in Latvia
title_fullStr Validation of the generalized anxiety disorder scales (GAD-7 and GAD-2) in primary care settings in Latvia
title_full_unstemmed Validation of the generalized anxiety disorder scales (GAD-7 and GAD-2) in primary care settings in Latvia
title_short Validation of the generalized anxiety disorder scales (GAD-7 and GAD-2) in primary care settings in Latvia
title_sort validation of the generalized anxiety disorder scales (gad-7 and gad-2) in primary care settings in latvia
topic Psychiatry
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9583259/
https://www.ncbi.nlm.nih.gov/pubmed/36276320
http://dx.doi.org/10.3389/fpsyt.2022.972628
work_keys_str_mv AT vrublevskajelena validationofthegeneralizedanxietydisorderscalesgad7andgad2inprimarycaresettingsinlatvia
AT renemanelubova validationofthegeneralizedanxietydisorderscalesgad7andgad2inprimarycaresettingsinlatvia
AT kiviteurtaneanda validationofthegeneralizedanxietydisorderscalesgad7andgad2inprimarycaresettingsinlatvia
AT rancanselmars validationofthegeneralizedanxietydisorderscalesgad7andgad2inprimarycaresettingsinlatvia